Radiotherapy with targeted and immunotherapy improved overall survival and progression-free survival for hepatocellular carcinoma with portal vein tumor thrombosis
RT combined with TKI and PD-1 inhibitor could significantly improve mOS and mPFS without inducing severe TRAEs or mortality.
Authors
- Lijuan Ding (ORCID: https://orcid.org/0000-0002-1692-5089)
- Ruipeng Zheng
- Jianing Ma (ORCID: https://orcid.org/0009-0001-3621-8744)
- Haifeng Zhang (ORCID: https://orcid.org/0000-0003-1966-6809)
- Shudong Wang
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
Publication Details
- Journal
- The Oncologist
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1093/oncolo/oyae209
- Citations
- 7
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.59